News of Note—HIV self test earns CE mark; Qiagen teams up on rare disease bioinformatics and more


> Sydney-based Atomo Diagnostics earned a CE mark for its HIV self test. Release | Read more from FierceMedTech

> Qiagen and Centogene are joining forces to offer more clinical testing solutions in rare genetic diseases. The partnership and comarketing agreement includes integrating the latter’s rare disease variant database into the former’s bioinformatics offerings. Release

> Siemens is partnering with lab equipment manufacturer Horiba Medical, to bring new laboratory hematology offerings to the global market. Release


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

> Finland’s Abacus Diagnostica has scored a CE mark for its rapid molecular test for the detection of norovirus. Release

> Olympus has signed on to distribute Ruhof Healthcare’s disposable endoscope valve set. The Guardian Endoscope Single-use Valve Set eliminates the need for cleaning, which can tamp down on hospital-acquired infections. Release | Read more about Olympus and its duodenoscopes

Suggested Articles

The FDA has cleared its first duodenoscope designed to make the intricate, moving and difficult-to-clean parts in the head of the device disposable.

The FDA has approved its first contact lens designed to effectively slow the progression of nearsightedness in children, starting in ages 8 to 12.

Novartis tapped Biofourmis to develop tracking programs for heart failure patients, as the latter acquired Biovotion, makers of clinical wearables.